comparemela.com

Latest Breaking News On - Karl doghramji - Page 1 : comparemela.com

Axsome Therapeutics Announces Results of CRESCENDO Narcolepsy Patient Survey Demonstrating Unmet Needs in Treated Narcolepsy Type 1 Patients

77% of narcolepsy type 1 patients continue to experience cataplexy attacks despite being treated 64% of narcolepsy type 1 patients continue to experience excessive daytime sleepiness, as assessed.

United-states
United-kingdom
Philadelphia
Pennsylvania
New-york
British
Karl-doghramji
Darren-opland
Mark-jacobson
Nasdaq
Axsome-therapeutics-inc
Narcolepsy-network

How Insomnia Affects Both Day and Night

Insomnia is often regarded by people as just being a nighttime problem, but it’s more than that, Michael J. Thorpy, MD, says.

Karl-doghramji
Michaelj-thorpy
Vikas-jain

vimarsana © 2020. All Rights Reserved.